Evidence map›Paper›PMID 33157263›Full record

ArticleNeuroImage2021

Identifying neural signatures mediating behavioral symptoms and psychosis onset: High-dimensional whole brain functional mediation analysis.

Oliver Y Chén, Hengyi Cao, Huy Phan, Guy Nagels, Jenna M Reinen, Jiangtao Gou, Tianchen Qian, Junrui Di, John Prince, Tyrone D Cannon and 1 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 3 countries.

Oliver Y ChénDepartment of Engineering Science, University of Oxford, Oxford OX1 4AR, United Kingdom. Electronic address: yibing.chen@seh.ox.ac.uk.
Hengyi CaoDepartment of Psychology, Yale University, New Haven 06510, CT, United States; Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Hempstead 11030, NY, United States; Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks 11004, NY, United States.
Huy PhanSchool of Electronic Engineering and Computer Science, Queen Mary University of London, London E1 4NS, United Kingdom.
Guy NagelsDepartment of Neurology, Universitair Ziekenhuis Brussel, 1090 Jette, Belgium.
Jenna M ReinenIBM Watson Research Center, Yorktown Heights, NY 10598, United States.
Jiangtao GouDepartment of Mathematics and Statistics, Villanova University, PA 19085, United States.
Tianchen QianDepartment of Statistics, Harvard University, Cambridge 02138, MA, United States; Department of Statistics, University of California Irvine, Irvine 92697, CA, United States.
Junrui DiDepartment of Biostatistics, Johns Hopkins University, Baltimore 21205, MD, United States.
John PrinceDepartment of Engineering Science, University of Oxford, Oxford OX1 4AR, United Kingdom.
Tyrone D CannonDepartment of Psychology, Yale University, New Haven 06510, CT, United States; Department of Psychiatry, Yale University, New Haven 06510, CT, United States.
Maarten de VosFaculty of Engineering Science, KU Leuven, Leuven 3001, Belgium; Faculty of Medicine, KU Leuven, Leuven 3001, Belgium; KU Leuven Institute for Artificial Intelligence, Leuven B-3000, Belgium.
University of Oxford · GBFeinstein Institute for Medical Research · USHarvard University · USIBM (United States) · USJohns Hopkins University · USQueen Mary University of London · GBUniversitair Ziekenhuis Brussel · BEVIB-KU Leuven Center for Microbiology · BEVillanova University · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
1/9 Predictors and Mechanisms of Conversion to PsychosisU01MH081902 · NIMH · YALE UNIVERSITY · PI CANNON, TYRONE D · 2008 to 2018
$12.4M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS U01 MH081902Wellcome TrustWellcome Trust 098461/Z/12/Z
6 · The paper itself

Abstract

Along the pathway from behavioral symptoms to the development of psychotic disorders sits the multivariate mediating brain. The functional organization and structural topography of large-scale multivariate neural mediators among patients with brain disorders, however, are not well understood. Here, we design a high-dimensional brain-wide functional mediation framework to investigate brain regions that intermediate between baseline behavioral symptoms and future conversion to full psychosis among individuals at clinical high risk (CHR). Using resting-state functional magnetic resonance imaging (fMRI) data from 263 CHR subjects, we extract an α brain atlas and a β brain atlas: the former underlines brain areas associated with prodromal symptoms and the latter highlights brain areas associated with disease onset. In parallel, we identify and separate mediators that potentially positively and negatively mediate symptoms and psychosis, respectively, and quantify the effect of each neural mediator on disease development. Taken together, these results paint a brain-wide picture of neural markers that are potentially mediating behavioral symptoms and the development of psychotic disorders; additionally, they underscore a statistical framework that is useful to uncover large-scale intermediating variables in a regulatory biological system.

Indexed as

Prodromal SymptomsBehavioral SymptomsBrainBrain MappingFemaleHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleMediation AnalysisPsychotic DisordersYoung Adult

Identifiers

PMID33157263
PMCPMC7836235
OpenAlexW3097655601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.